A detailed history of Srs Capital Advisors, Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 204 shares of MEDP stock, worth $69,908. This represents 0.01% of its overall portfolio holdings.

Number of Shares
204
Previous 206 0.97%
Holding current value
$69,908
Previous $84,000 19.05%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$320.58 - $457.29 $641 - $914
-2 Reduced 0.97%
204 $68,000
Q2 2024

Aug 06, 2024

BUY
$372.0 - $424.34 $75,144 - $85,716
202 Added 5050.0%
206 $84,000
Q1 2024

May 14, 2024

SELL
$284.87 - $413.31 $569 - $826
-2 Reduced 33.33%
4 $1,000
Q3 2022

Nov 03, 2022

SELL
$145.13 - $182.49 $290 - $364
-2 Reduced 25.0%
6 $1,000
Q4 2021

Feb 08, 2022

BUY
$182.74 - $227.9 $1,461 - $1,823
8 New
8 $2,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.